A McGill University study suggests a new anti-depressant drug works by raising levels of endocannabinoids -- similar to a substance found in marijuana.
The study suggests the new drug, called URB597, might represent a safer alternative to use of marijuana for treatment of pain and depression, and open the door to new and improved treatments for clinical depression.
In pre-clinical laboratory tests researchers found URB597 increased the production of endocannabinoids by blocking their degradation, resulting in measurable antidepressant effects.
"This is the first time it has been shown a drug that increases endocannabinoids in the brain can improve your mood," said lead investigator Dr. Gabriella Gobbi, a researcher at Montreal and McGill Universities.
The researchers, including scientists from the University of California-Irvine, were able to measure serotonin and noradrenaline activity as a result of the increased endocannabinoids.
"The results were similar to the effect we might expect from the use of commonly prescribed antidepressants, which are effective on only around 30 percent of the population," said Gobbi. "Our discovery strengthens the case for URB597 as a safer, non-addictive, non-psychotropic alternative to cannabis for the treatment of pain and depression."
Copyright 2005 by United Press International
Related stories:
Marijuana-like brain chemicals work as antidepressant
American and Italian researchers have found that boosting the amounts of a marijuana-like brain transmitter called anandamide produces antidepressant effects in test rats.
Parkinson's disease: Treatment breakthrough in mice opens new path
Marijuana-like chemicals in the brain may point to a treatment for the debilitating condition of Parkinson's disease. In a study to be published in the Feb. 8 issue of
Nature, researchers from the Stanford University School of Medicine report that endocannabinoids, naturally occurring chemicals found in the brain that are similar to the active compounds in marijuana and hashish, helped trigger a dramatic improvement in mice with a condition similar to Parkinson's.
Report: US drug use shows little change in 2007
(AP) -- Cocaine and methamphetamine use among young adults declined significantly last year as supplies dried up, leading to higher prices and reduced purity, the government reports. Overall use of illicit drugs showed little change.
Medicinal marijuana effective for neuropathic pain in HIV
In a double-blind, placebo-controlled clinical trial to assess the impact of smoked medical cannabis, or marijuana, on the neuropathic pain associated with HIV, researchers at the University of California, San Diego School of Medicine found that reported pain relief was greater with cannabis than with a placebo. The study, sponsored by the University of California Center for Medical Cannabis Research (CMCR) based at UC San Diego, will be published on line, August 6 in the journal
Neuropsychopharmacology.
Black girls who use marijuana engage in riskier sex, have higher STD rate
Black girls who use marijuana are more likely to engage in risky sexual acts and contract a sexually transmitted disease, a new study finds.
Energy drinks linked to risk-taking behaviors among college students
Over the last decade, energy drinks -- such as Red Bull, Monster and Rockstar -- have become nearly ubiquitous on college campuses. The global market for these types of drinks currently exceeds $3 billion a year and new products are introduced annually.
Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana
Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of
Archives of General Psychiatry, one of the JAMA/Archives journals.
Treatment for cigarette, alcohol and drug use in pregnancy improves outcomes for mom and baby
Pregnant women who receive treatment for substance abuse early in their pregnancy can achieve the same health outcomes as pregnant women with no substance abuse, according to a Kaiser Permanente study published online in the
Journal of Perinatology.